Willem Gielen Person-Info 

( Ich bin Willem Gielen)

News

Biostrap is being utilized for a study conducted by the AP Newsapnews.com › press-release › pr-newswire

apnews.com
· ... effects of COVID-19 and symptoms still seem diffused and vary from case to case,” Biostrap Chief Medical Officer Dr. Willem Gielen said.

History of Changes for Study: NCT

clinicaltrials.gov
Contact: Willem Gielen, MD, PhD . Principal Investigator: Willem Gielen, MD. Netherlands, Zuid-Holland. Medisch Centrum Haaglanden
Dossier exportieren
+1